FR2693723B1 - Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation. - Google Patents

Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation.

Info

Publication number
FR2693723B1
FR2693723B1 FR9308452A FR9308452A FR2693723B1 FR 2693723 B1 FR2693723 B1 FR 2693723B1 FR 9308452 A FR9308452 A FR 9308452A FR 9308452 A FR9308452 A FR 9308452A FR 2693723 B1 FR2693723 B1 FR 2693723B1
Authority
FR
France
Prior art keywords
phenylethyl
beta
preparation process
amine derivatives
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9308452A
Other languages
English (en)
Other versions
FR2693723A1 (fr
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of FR2693723A1 publication Critical patent/FR2693723A1/fr
Application granted granted Critical
Publication of FR2693723B1 publication Critical patent/FR2693723B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9308452A 1992-07-17 1993-07-09 Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation. Expired - Fee Related FR2693723B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (2)

Publication Number Publication Date
FR2693723A1 FR2693723A1 (fr) 1994-01-21
FR2693723B1 true FR2693723B1 (fr) 1994-10-28

Family

ID=10718914

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9308453A Expired - Fee Related FR2693653B1 (fr) 1992-07-17 1993-07-09 Compositions thérapeutiques à base de dérivés de la N-(phényléthyl-beta-ol) amine.
FR9308452A Expired - Fee Related FR2693723B1 (fr) 1992-07-17 1993-07-09 Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9308453A Expired - Fee Related FR2693653B1 (fr) 1992-07-17 1993-07-09 Compositions thérapeutiques à base de dérivés de la N-(phényléthyl-beta-ol) amine.

Country Status (32)

Country Link
US (1) US5447942A (fr)
JP (1) JP3204811B2 (fr)
AT (1) AT403693B (fr)
AU (1) AU672791B2 (fr)
BE (1) BE1006429A3 (fr)
CA (1) CA2100381C (fr)
CH (1) CH687705A5 (fr)
DE (1) DE4323976C2 (fr)
DK (1) DK84793A (fr)
DZ (1) DZ1704A1 (fr)
ES (1) ES2067417B1 (fr)
FI (1) FI933235A (fr)
FR (2) FR2693653B1 (fr)
GB (2) GB9215274D0 (fr)
GR (1) GR1001565B (fr)
HK (1) HK52596A (fr)
HU (1) HUT64757A (fr)
IE (1) IE73266B1 (fr)
IN (1) IN183086B (fr)
LU (1) LU88383A1 (fr)
MA (1) MA22937A1 (fr)
MY (1) MY109395A (fr)
NL (1) NL9301241A (fr)
NO (1) NO302946B1 (fr)
NZ (1) NZ248041A (fr)
OA (1) OA09838A (fr)
PL (1) PL173783B1 (fr)
PT (1) PT101308B (fr)
RU (1) RU2060252C1 (fr)
SE (1) SE503805C2 (fr)
TN (1) TNSN93081A1 (fr)
ZA (1) ZA934667B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025920A2 (fr) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulateurs de neurotransmetteurs du systeme nerveux central
WO2020148325A1 (fr) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Modulateurs de lxr neutres

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
NZ211822A (en) * 1984-04-17 1988-11-29 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical compositions
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
EP0286242A3 (fr) * 1987-03-12 1989-08-09 Glaxo Group Limited Dérivés d'ethanolamine, procédés pour leur preparations et compositions pharmaceutiques les contenant
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
TW209832B (fr) * 1989-10-10 1993-07-21 Glaxo Group Ltd

Also Published As

Publication number Publication date
IE73266B1 (en) 1997-05-21
ATA142793A (de) 1997-09-15
AU672791B2 (en) 1996-10-17
SE9302437D0 (sv) 1993-07-16
DK84793A (da) 1994-01-18
AU4204293A (en) 1994-01-20
AT403693B (de) 1998-04-27
DE4323976A1 (de) 1994-01-20
FR2693723A1 (fr) 1994-01-21
SE503805C2 (sv) 1996-09-09
NO302946B1 (no) 1998-05-11
CA2100381A1 (fr) 1994-01-18
GR1001565B (el) 1994-05-31
TNSN93081A1 (fr) 1994-03-17
MA22937A1 (fr) 1994-04-01
GB2268742A (en) 1994-01-19
FR2693653A1 (fr) 1994-01-21
LU88383A1 (fr) 1994-04-01
HU9302057D0 (en) 1993-10-28
JP3204811B2 (ja) 2001-09-04
ZA934667B (en) 1994-01-25
RU2060252C1 (ru) 1996-05-20
GB9314718D0 (en) 1993-08-25
HUT64757A (en) 1994-02-28
FI933235A (fi) 1994-01-18
NO932383L (no) 1994-01-18
CA2100381C (fr) 2004-09-21
DE4323976C2 (de) 2003-05-28
FI933235A0 (fi) 1993-07-16
DK84793D0 (da) 1993-07-16
CH687705A5 (fr) 1997-01-31
ES2067417B1 (es) 1995-11-16
IE930472A1 (en) 1994-01-26
NO932383D0 (no) 1993-06-29
US5447942A (en) 1995-09-05
NZ248041A (en) 1994-06-27
SE9302437L (sv) 1994-01-18
ES2067417A1 (es) 1995-03-16
JPH06157492A (ja) 1994-06-03
MY109395A (en) 1997-01-31
NL9301241A (nl) 1994-02-16
PL299693A1 (en) 1994-03-21
HK52596A (en) 1996-04-03
GB9215274D0 (en) 1992-09-02
PT101308B (pt) 1999-10-29
BE1006429A3 (fr) 1994-08-23
PT101308A (pt) 1994-05-31
OA09838A (fr) 1994-08-15
PL173783B1 (pl) 1998-04-30
GB2268742B (en) 1995-11-08
IN183086B (fr) 1999-09-04
FR2693653B1 (fr) 1994-10-28
DZ1704A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
DZ2051A1 (fr) Catalyseur et procédé de préparation d'hydrocarbures.
OA09387A (fr) "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DZ2370A1 (fr) Procédé de préparation d'hydrocarbures
DZ1910A1 (fr) Nouvelles streptogramines et procédé de préparation de streptogramines par mutasynthèse.
FR2696744B1 (fr) Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2716881B1 (fr) Procédé de préparation et de purification d'Iopamidol.
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
OA09840A (fr) dérivés de pipéridine, leur préparation et leur application en thérapeutique
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FR2693723B1 (fr) Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2696745B1 (fr) Procédé de préparation de dérivés de phényltétrazole.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2693197B1 (fr) Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
FR2694933B1 (fr) Procédé de préparation d'isocyanates d'acyle.
DZ1655A1 (fr) Dérivés de la benzofuranylimidazole ainsi que leurprocédé de préparation.
DZ1460A1 (fr) Nouveaux dérivés du sélénophèn ainsi que leur procédé de préparation.
FR2699919B1 (fr) Dérivés d'imidazole, leur procédé de préparation et leur application en thérapeutique.
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2698874B1 (fr) Procédé de préparation de dérivés d'acétoamides, d'acétothioamides et d'acétosélénoamides, en particulier de dérivés de carbamoylméthylphosphines et carbamoylméthylphosphines ainsi obtenues.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100331